Holen Sie sich die Stockscreener-App
172.80
0.56%
0.80
Handel nachbörslich:
173.09
0.29
+0.17%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Danaher Corp Aktie (DHR) Neueste Nachrichten
RBC Capital Resumes Coverage of Danaher Corporation (DHR) - Insider Monkey
Danaher Corp. stock (US2358511028): dividend timeline and institutional interest in focus - AD HOC NEWS
Danaher Corp. May Be the Smartest Bet in Biotech Right Now - AOL.com
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum Asia
Masimo earnings in focus as Danaher deal nears close - Investing.com
Danaher Raises $3 Billion in Record Private-Placement Bond Sale - Bloomberg.com
Danaher Targets Carbon Capture And AI CMC To Shape Long Term Growth - Yahoo Finance
Danaher (DHR) Stock Price, News & Analysis $DHR - MarketBeat
Danaher stock (US2358511028): diagnostics spin?off and Q1 earnings reshape the portfolio - AD HOC NEWS
Danaher Corp. stock (US2358511028): earnings beat keeps focus on life sciences recovery - AD HOC NEWS
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR) - Barchart.com
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Eagle Capital Management Bet on Danaher (DHR) for Its Mid-Teens EPS Growth - Yahoo Finance
Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence - GlobeNewswire Inc.
Danaher stock (US2358511028): spin-off, diagnostics focus and what the latest numbers reveal - AD HOC NEWS
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead? - The Globe and Mail
Pall to Address a Key Decarbonization Challenge with Additively Manufactured Filtration - Carroll County Mirror-Democrat
Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal - Yahoo Finance
Danaher Corp. stock (US2358511028): insider awards highlight leadership confidence after guidance li - AD HOC NEWS
Danaher (NYSE: DHR) director Linda Filler receives stock and option grants - Stock Titan
Danaher (NYSE: DHR) SVP uses 281 shares for tax withholding, retains 8,291 - Stock Titan
[Form 4] DANAHER CORP /DE/ Insider Trading Activity - Stock Titan
Alan G. Spoon (DHR) awarded RSUs and stock options in new Danaher Form 4 - Stock Titan
Danaher (NYSE: DHR) director awarded RSUs and long-dated stock options - Stock Titan
Danaher (NYSE: DHR) director Teri List granted RSUs and stock options as board compensation - Stock Titan
Danaher (NYSE: DHR) awards director Zerhouni RSUs and stock options - Stock Titan
Danaher (NYSE: DHR) director granted RSUs and options in new award - Stock Titan
Danaher (DHR) director Charles Lamanna awarded RSUs and 1,699-share option - Stock Titan
Danaher shares climb as analysts turn more constructive after Q1 guidance lift - Quiver Quantitative
Danaher Corp. stock (US2358511028): restructuring after spin-off, new focus on life sciences - AD HOC NEWS
Northwestern Mutual Wealth Management Co. Acquires 186,584 Shares of Danaher Corporation $DHR - MarketBeat
Danaher stock (US2358511028): Q1 figures, dividend and analyst views in focus - AD HOC NEWS
Danaher stock (US2358511028): earnings momentum and dividend in focus for US investors - AD HOC NEWS
Masimo Corp stock (US5747951003): earnings, Danaher deal and what’s next for the medical-tech spec - AD HOC NEWS
Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks - Insider Monkey
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
DoorDash Inc stock (US2358511028): Q1 2026 profit beat keeps growth story in focus - AD HOC NEWS
Danaher Corporation Trade Ideas — AQUISEU:DAPD - TradingView
Danaher Valuation Reset Highlights Recurring Revenues And Lean Operating Framework - Yahoo Finance
Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says - marketscreener.com
DHR Reinstated by RBC Capital -- Price Target Set at $200 - GuruFocus
Danaher Stock: Analyst Estimates & Ratings - Barchart
Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers - AD HOC NEWS
Danaher (DHR) Receives Outperform Rating from RBC Capital with $200 Price Target - GuruFocus
RBC Capital assumes Danaher stock coverage with outperform rating - Investing.com UK
RBC Capital assumes Danaher stock coverage with outperform rating By Investing.com - Investing.com Nigeria
DoorDash Inc stock (US2358511028): investors weigh latest results and US food delivery outlook - AD HOC NEWS
Jim Cramer Discusses the Performance of Danaher and Its Peers - Insider Monkey
Danaher stock (US2358511028): Shares decline amid four-day losing streak - AD HOC NEWS
The Escalator: Rx&O, Danaher, Ruder Finn and more - Medical Marketing and Media
Transcript : Danaher Corporation Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11 - marketscreener.com
Is Danaher Corporation (DHR) A Good Stock To Buy Now? - Yahoo Finance
Jim Cramer’s Take on 5 Stocks: Home Depot, Procter & Gamble, and Danaher - Insider Monkey
0.05%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):